Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Roth

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Cell Metabolism|May 8, 2024
A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1Suchira Gallage, Adnan Ali, Jose Efren Barragan Avila, et al.
Plos One|November 25, 2025
GerPaCyst - The trial protocol of the prospective, multicenter, interdisciplinary German Pancreas Club Cyst RegistryKim Christin Honselmann, Jonathan Marschner, Anna Staufenbiel, et al.
Nature|March 25, 2021
Auto-aggressive CXCR6<sup>+</sup> CD8 T cells cause liver immune pathology in NASHMichael Dudek, Dominik Pfister, Sainitin Donakonda, et al.
Biological Research|August 13, 2023
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in EurasiansMargherita Piccardi, Manuel Gentiluomo, Stefania Bertoncini, et al.
International Journal of Cancer|September 25, 2024
Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterizationFernando Gálvez-Montosa, Giulia Peduzzi, José Manuel Sanchez-Maldonado, et al.
Frontiers in Genetics|September 16, 2021
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer RiskYe Lu, Chiara Corradi, Manuel Gentiluomo, et al.
Nature|February 4, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillanceXin Li, Cynthia Lebeaupin, Aikaterini Kadianaki, et al.
Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Cell Metabolism|May 8, 2024
A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1Suchira Gallage, Adnan Ali, Jose Efren Barragan Avila, et al.
Plos One|November 25, 2025
GerPaCyst - The trial protocol of the prospective, multicenter, interdisciplinary German Pancreas Club Cyst RegistryKim Christin Honselmann, Jonathan Marschner, Anna Staufenbiel, et al.
Nature|March 25, 2021
Auto-aggressive CXCR6<sup>+</sup> CD8 T cells cause liver immune pathology in NASHMichael Dudek, Dominik Pfister, Sainitin Donakonda, et al.
Biological Research|August 13, 2023
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in EurasiansMargherita Piccardi, Manuel Gentiluomo, Stefania Bertoncini, et al.
International Journal of Cancer|September 25, 2024
Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterizationFernando Gálvez-Montosa, Giulia Peduzzi, José Manuel Sanchez-Maldonado, et al.
Frontiers in Genetics|September 16, 2021
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer RiskYe Lu, Chiara Corradi, Manuel Gentiluomo, et al.
Nature|February 4, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillanceXin Li, Cynthia Lebeaupin, Aikaterini Kadianaki, et al.
Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.
Pageof 8